Valproic acid and Zarontin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Valproic acid (valproic acid) and Zarontin (ethosuximide). Common drug interactions include oedema peripheral among females and nephritis sle among males.

The phase IV clinical study analyzes what interactions people have when they take Valproic acid and Zarontin. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Valproic acid?

Valproic acid has active ingredients of valproic acid. It is often used in epilepsy. eHealthMe is studying from 36,193 Valproic acid users. Check the latest studies of Valproic acid.

What is Zarontin?

Zarontin has active ingredients of ethosuximide. It is often used in petit mal seizure. eHealthMe is studying from 987 Zarontin users. Check the latest studies of Zarontin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Jul, 04, 2026

30 people who take Valproic acid and Zarontin together, and have interactions are studied.

Valproic acid and Zarontin drug interactions.

What are the common drug interactions of Valproic Acid and Zarontin, by gender? *:

female:

  1. Oedema peripheral (superficial swelling)
  2. Acute pulmonary oedema (sudden deposit of fluid in the lung))
  3. Mitral valve disease (disease of mitral valve of heart)
  4. Myocarditis (inflammation of heart muscle myocardium)
  5. Decreased appetite
  6. Acute hepatic failure
  7. Adverse drug reaction
  8. Hospitalisation
  9. Hyperthermia malignant (disease passed down through families that causes a fast rise in body temperature (fever) and severe muscle contractions)
  10. Nausea (feeling of having an urge to vomit)

male:

  1. Nephritis sle (an inflammation of the kidney caused by systemic lupus erythematosus (sle), a disease of the immune system)
  2. Speech disorder
  3. Productive cough
  4. Proteinuria present
  5. Renal disorder (kidney disease)
  6. Skin papilloma (a general medical term for a tumour of the skin or mucous membrane with finger-like projections)
  7. Thrombocytopenia (decrease of platelets in blood)
  8. Tonic clonic movements (generalized seizure that affects the entire brain)
  9. Tooth discolouration (a change in colour of teeth)
  10. Agitation (state of anxiety or nervous excitement)

What are the common drug interactions of Valproic Acid and Zarontin, by age (0-1 to 60+)? *:

0-1:

  1. Decreased appetite
  2. Gait disturbance
  3. Insomnia (sleeplessness)
  4. Irritability
  5. Speech disorder

2-9:

  1. Acute hepatic failure
  2. Hyperthermia malignant (disease passed down through families that causes a fast rise in body temperature (fever) and severe muscle contractions)
  3. Nephritis sle (an inflammation of the kidney caused by systemic lupus erythematosus (sle), a disease of the immune system)
  4. Renal failure acute (rapid kidney dysfunction)
  5. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  6. Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure)
  7. Tooth discolouration (a change in colour of teeth)
  8. Asthenia (weakness)
  9. Bacterial test positive
  10. Coombs direct test positive

10-19:

  1. Adverse drug reaction
  2. Decreased appetite
  3. Hospitalisation
  4. Nausea (feeling of having an urge to vomit)
  5. Petit mal epilepsy (absence seizure)
  6. Weight decreased

20-29:

  1. Agitation (state of anxiety or nervous excitement)
  2. Tonic clonic movements (generalized seizure that affects the entire brain)

30-39:

  1. Acute pulmonary oedema (sudden deposit of fluid in the lung))
  2. Mitral valve disease (disease of mitral valve of heart)
  3. Myocarditis (inflammation of heart muscle myocardium)
  4. Oedema peripheral (superficial swelling)
  5. Priapism (prolonged and painful erection that can last from several hours up to a few days)

40-49:

n/a

50-59:

  1. Oedema peripheral (superficial swelling)
  2. Phlebitis (inflammation of the walls of a vein)
  3. Venous thrombosis (blood clot (thrombus) that forms within a vein)

60+:

n/a

What are the existing conditions these people have? *

  1. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 6 people, 20.00%
  2. Febrile Convulsion (a convulsion associated with a significant rise in body temperature): 5 people, 16.67%
  3. Encephalopathy (functioning of the brain is affected by some agent or condition): 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Valproic acid and Zarontin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Valproic acid and Zarontin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Valproic acid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zarontin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Valproic acid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zarontin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on valproic acid and ethosuximide (the active ingredients of Valproic acid and Zarontin, respectively), and Valproic acid and Zarontin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: